Great West Life Assurance CO Rocket Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,276 shares of RCKT stock, worth $78,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,276

Previous 6,276 -0.0%

Holding current value

$78,763

Previous $135,000 14.07%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$16.78 - $31.94 $21,629 - $41,170	1,289 Added 25.85%	6,276 $187,000
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $50,755 - $81,000	3,368 Added 208.03%	4,987 $102,000
Q2 2023 Aug 10, 2023	SELL	$16.59 - $23.6 $21,600 - $30,727	-1,302 Reduced 44.57%	1,619 $32,000
Q4 2022 Feb 10, 2023	BUY	$15.5 - $22.76 $6,618 - $9,718	427 Added 17.12%	2,921 $57,000
Q3 2022 Nov 01, 2022	BUY	$12.37 - $18.41 $30,850 - $45,914	2,494 New	2,494 $40,000
Q2 2022 Aug 09, 2022	BUY	$7.96 - $16.64 $859 - $1,797	108 Added 4.76%	2,377 $32,000
Q1 2022 May 12, 2022	BUY	$13.16 - $23.68 $1,473 - $2,652	112 Added 5.19%	2,269 $39,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $2,259 - $3,782	105 Added 5.12%	2,157 $47,000
Q3 2020 Nov 17, 2020	BUY	$20.5 - $28.59 $9,266 - $12,922	452 Added 28.25%	2,052 $46,000
Q3 2020 Nov 13, 2020	SELL	$20.5 - $28.59 $9,266 - $12,922	-452 Reduced 22.03%	1,600 $36,000
Q4 2019 Feb 11, 2020	BUY	$11.07 - $24.23 $22,715 - $49,719	2,052 New	2,052 $46,000
Q3 2019 Oct 25, 2019	SELL	$10.85 - $14.78 $41,967 - $57,169	-3,868 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$14.58 - $23.0 $56,395 - $88,964	3,868 New	3,868 $76,000

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $950M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Rocket Pharmaceuticals, Inc. Transaction History